Abbott secures UPC injunction in diabetes monitoring device appeal against Chinese rival
Abbott Diabetes Care has secured a UPC injunction against Sinocare’s GlucoMen iCan, with appeal judges overturning a refusal and finding indirect infringement and likely validity. Judges cited urgency, warning that continued...To view the full article, register now.
Already a subscriber? Click here to view full article